Last reviewed · How we verify
Acetylsalicylic acid lysinate
At a glance
| Generic name | Acetylsalicylic acid lysinate |
|---|---|
| Also known as | Aspirin, Ascal, Ascal Cardio/Neuro, Carbasalate Calcium |
| Sponsor | Medical University of Vienna |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome (PHASE3)
- Vitamin D Versus Sildenafil Citrate in Fetal Growth Restriction (PHASE1)
- Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI) (PHASE3)
- Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT) (PHASE3)
- Does Acetylsalicylic Acid Reduce the Mortality of Patients Admitted to an Intensive Care Unit (PHASE3)
- Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone (PHASE3)
- Different Doses of IVIG for Kawasaki Disease (PHASE3)
- Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Acetylsalicylic acid lysinate CI brief — competitive landscape report
- Acetylsalicylic acid lysinate updates RSS · CI watch RSS
- Medical University of Vienna portfolio CI